ArticleBreast cancer research and treatment2019
HER2 positive breast cancer patients having HER2 loss after neoadjuvant chemotherapy should still be treated with adjuvant anti-HER2 treatment.
Kadri AltundagPubMed ↗Publisher ↗
No numbers read from the abstract.